Aug 3, 2022 01:30AM

Apr 23, 2021 01:30AM

Jan 22, 2021 01:30AM

Jan 20, 2021 01:30AM

Jan 6, 2021 01:30AM

Jan 5, 2021 01:30AM

Dec 11, 2020 01:30AM Nicox’s Partner Fera Pharmaceuticals to Investigate Naproxcinod as Potential Covid-19 Adjuvant Treatment

Nov 25, 2020 02:00AM

Nov 23, 2020 01:30AM

Nov 10, 2020 01:30AM

Oct 29, 2020 02:30AM

Oct 26, 2020 02:30AM

Oct 23, 2020 01:30AM

Oct 20, 2020 01:30AM Nicox Announces Third Quarter 2020 Business Update and Financial Highlights

Oct 13, 2020 01:30AM

Sep 23, 2020 11:40AM

Sep 22, 2020 01:30AM

Sep 18, 2020 01:30AM

Sep 10, 2020 01:30AM

Sep 2, 2020 01:30AM

Aug 12, 2020 01:30AM Nicox Partners ZERVIATE in the Gulf and Arab Markets

Aug 5, 2020 03:15AM

Aug 5, 2020 01:30AM

Jul 31, 2020 01:30AM

Jul 17, 2020 01:30AM

Jul 15, 2020 01:30AM

Jul 10, 2020 02:30AM

Jul 10, 2020 01:30AM Nicox Strengthens Cash Position With Divestment of its VISUfarma Shareholding

Jun 2, 2020 01:30AM

Apr 17, 2020 01:30AM

Apr 8, 2020 01:30AM

Apr 2, 2020 01:30AM

Mar 31, 2020 01:30AM

Mar 11, 2020 02:35AM

Mar 11, 2020 02:30AM Nicox to Receive €15 Million and Half of the Cost of the Second NCX 470 Phase 3 Clinical Trial from Ocumension Therapeutics under Amended Agreement

Mar 9, 2020 02:30AM

Mar 6, 2020 01:30AM

Mar 5, 2020 01:30AM

Feb 3, 2020 01:30AM

Feb 3, 2020 01:30AM

Jan 21, 2020 01:30AM

Jan 16, 2020 01:30AM Nicox’s Partner Secures Additional Approvals of VYZULTA (latanoprostene bunod ophthalmic solution), 0.024% in Hong Kong and Argentina

Jan 13, 2020 01:30AM

Dec 19, 2019 01:30AM

Mar 19, 2019 02:31AM

Mar 15, 2019 02:31AM

Mar 6, 2019 01:31AM

Jan 29, 2019 01:30AM

Jan 28, 2019 01:31AM Nicox Establishes High-Profile Glaucoma Clinical Advisory Board

Jan 25, 2019 01:31AM

21,519 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All